Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Diesinger T, Buko V, Lautwein A, Dvorsky R, Belonovskaya E, Lukivskaya O, Naruta E, Kirko S, Andreev V, Buckert D, Bergler S, Renz C, Schneider E, Kuchenbauer F, Kumar M, Günes C, Büchele B, Simmet T, Müller-Enoch D, Wirth T, Haehner T.
Diesinger T, et al. Among authors: lautwein a.
PLoS One. 2020 Jul 23;15(7):e0235990. doi: 10.1371/journal.pone.0235990. eCollection 2020.
PLoS One. 2020.
PMID: 32701948
Free PMC article.